Seres Therapeutics (MCRB) Q2 2025 Earnings

May 7Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-3.93
-1.37
1.19
3.75

Details

Expected EPS
0.102028
Actual EPS
3.75
Surprise EPS
3.65
Surprise Percent
+3,575.46%

Description

⁨Seres Therapeutics⁩ (⁦MCRB⁩) has reported earnings of ⁦3.75⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts